Discussion  by unknown
JOURNAL OF VASCULAR SURGERY
Volume 57, Number 5 Kougias et al 133710. Rao SV, Jollis JG, Harrington RA, Granger CB, Newby LK,
Armstrong PW, et al. Relationship of blood transfusion and clinical
outcomes in patients with acute coronary syndromes. JAMA 2004;292:
1555-62.
11. Sabatine MS, Morrow DA, Giugliano RP, Burton PB, Murphy SA,
McCabe CH, et al. Association of hemoglobin levels with clinical
outcomes in acute coronary syndromes. Circulation 2005;111:2042-9.
12. Wu WC. Does blood transfusion increase mortality risk in acute
myocardial infarction? Am J Cardiol 2008;102:1116-7.
13. Wu WC, Rathore SS, Wang Y, Radford MJ, Krumholz HM. Blood
transfusion in elderly patients with acute myocardial infarction. N Engl
J Med 2001;345:1230-6.
14. Wu WC, Schifftner TL, Henderson WG, Eaton CB, Poses RM,
Uttley G, et al. Preoperative hematocrit levels and postoperative
outcomes in older patients undergoing noncardiac surgery. JAMA
2007;297:2481-8.
15. Carson JL, Terrin ML, Noveck H, Sanders DW, Chaitman BR,
Rhoads GG, et al. Liberal or restrictive transfusion in high-risk patients
after hip surgery. N Engl J Med 2011;365:2453-62.
16. Hajjar LA, Vincent JL, Galas FR, Nakamura RE, Silva CM,
Santos MH, et al. Transfusion requirements after cardiac surgery: the
TRACS randomized controlled trial. JAMA 2010;304:1559-67.
17. Bush RL, Pevec WC, Holcroft JW. A prospective, randomized trial
limiting perioperative red blood cell transfusions in vascular patients.
Am J Surg 1997;174:143-8.
18. Cooper HA, Rao SV, Greenberg MD, Rumsey MP, McKenzie M,
Alcorn KW, et al. Conservative versus liberal red cell transfusion in
acute myocardial infarction (the crit randomized pilot study). Am J
Cardiol 2011;108:1108-11.
19. Chesebro JH, Knatterud G, Roberts R, Borer J, Cohen LS, Dalen J,
et al. Thrombolysis in myocardial infarction (TIMI) trial, phase I:
a comparison between intravenous tissue plasminogen activator and
intravenous streptokinase. Clinical ﬁndings through hospital discharge.
Circulation 1987;76:142-54.
20. Weiss G, Goodnough LT. Anemia of chronic disease. N Engl J Med
2005;352:1011-23.
21. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA,
Fowkes FG. Inter-Society Consensus for the Management of Periph-
eral Arterial Disease (TASC II). J Vasc Surg 2007;45(Suppl S):S5-67.
22. Shishehbor MH, Madhwal S, Rajagopal V, Hsu A, Kelly P, Gurm HS,
et al. Impact of blood transfusion on short- and long-term mortality in
patients with ST-segment elevation myocardial infarction. JACC Car-
diovasc Interv 2009;2:46-53.
23. Wright RS, Anderson JL, Adams CD, Bridges CR, Casey DE Jr.,
Ettinger SM, et al. 2011 ACCF/AHA focused update incorporatedinto the ACC/AHA 2007 guidelines for the management of
patients with unstable angina/non-ST-elevation myocardial infarc-
tion: a report of the American College of Cardiology Foundation/
American Heart Association Task Force on practice guidelines
developed in collaboration with the American Academy of Family
Physicians, Society for Cardiovascular Angiography and Interven-
tions, and the Society of Thoracic Surgeons. J Am Coll Cardiol
2011;57:e215-367.
24. Fleischmann KE, Beckman JA, Buller CE, Calkins H, Fleisher LA,
Freeman WK, et al. 2009 ACCF/AHA focused update on perioper-
ative beta blockade. J Am Coll Cardiol 2009;54:2102-28.
25. Mascha EJ, Sessler DI. Statistical grand rounds: design and analysis of
studies with binary-event composite endpoints: guidelines for anes-
thesia research. Anesth Analg 2011;112:1461-71.
26. Mascha EJ, Imrey PB. Factors affecting power of tests for multiple
binary outcomes. Stat Med 2010;29:2890-904.
27. Musallam KM, Tamim HM, Richards T, Spahn DR, Rosendaal FR,
Habbal A, et al. Preoperative anaemia and postoperative outcomes in
non-cardiac surgery: a retrospective cohort study. Lancet 2011;378:
1396-407.
28. Foss NB, Kristensen MT, Jensen PS, Palm H, Krasheninnikoff M,
Kehlet H. The effects of liberal versus restrictive transfusion thresholds
on ambulation after hip fracture surgery. Transfusion 2009;49:
227-34.
29. Hebert PC, Wells G, Blajchman MA, Marshall J, Martin C,
Pagliarello G, et al. A multicenter, randomized, controlled clinical trial
of transfusion requirements in critical care. Transfusion requirements in
critical care investigators, Canadian critical care trials group. N Engl J
Med 1999;340:409-17.
30. Hebert PC, Yetisir E, Martin C, Blajchman MA, Wells G, Marshall J,
et al. Is a low transfusion threshold safe in critically ill patients with
cardiovascular diseases? Crit Care Med 2001;29:227-34.
31. Carson JL, Grossman BJ, Kleinman S, Tinmouth AT, Marques MB,
Fung MK, et al. Red blood cell transfusion: a clinical practice guideline
from the AABB. Ann Intern Med 2012;157:49-58.
32. Veenith T, Sharples L, Gerrard C, Valchanov K, Vuylsteke A. Survival
and length of stay following blood transfusion in octogenarians
following cardiac surgery. Anaesthesia 2010;65:331-6.
33. Casutt M, Seifert B, Pasch T, Schmid ER, Turina MI, Spahn DR.
Factors inﬂuencing the individual effects of blood transfusions on
oxygen delivery and oxygen consumption. Crit Care Med 1999;27:
2194-200.Submitted Jun 21, 2012; accepted Oct 17, 2012.DISCUSSIONDr Ronald Fairman (Philadelphia, Pa). My ﬁrst question is,
did you look at the timing of transfusion and did that have an
impact on your results, whether the transfusions were administered
only during the surgery as opposed to the early postoperative or
late postoperative periods?
Dr Panos Kougias. We sure did look at that and it had
a minor impact. The intraoperative transfusion actually had less
of an impact than the postop. But overall, data were collected up
to the point of the event. We tried to avoid the temporal bias
that some observational centers have by collecting data that
included transfusions even after the event of interest had occurred.
So I would say that the postoperative, actually, transfusions were
a more signiﬁcant predictor than the intraoperative.Dr Rabih Chaer (Pittsburgh, Pa). My question really pertains
to the high cardiac risk patient. Your propensity score is as good as
what goes into your model. I brieﬂy looked at the list of the
elements that you included in your analysis, but perhaps the high-
est effect of anemia is dependent on how much it increases myocar-
dial demand. Did you look at whether those patients were beta
blocked or not, because this might impact on the coronary
outcomes of anemia.
DrKougias.Absolutely. Beta blockade, use of statin and,more
interestingly, use of aspirin or Plavix were introduced in the model.
We also included, when we did the propensity score calculation, the
patient’s risk status in terms of revised cardiac risk index. So the
propensity score we had was all adjusted for all those covariates.
